UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 720

Sortiert nach

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla

Brain (London, England : 1878), 2011-12, Vol.134 (12), p.3599-3612

2011

Volltextzugriff (PDF)

Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study

Frontiers in neurology, 2021-12, Vol.12, p.632749-632749

2021

Volltextzugriff (PDF)

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (3), p.331-338

2014

Volltextzugriff (PDF)

P0836 : Treatment response rates in a real life cohort of patients with advanced liver disease and organ transplantation

Journal of hepatology, 2015-04, Vol.62, p.S651-S651

2015

Volltextzugriff (PDF)

P0130 : VITRO-Score (vWF-Ag/thrombocytes) predicts mortality in patients with liver cirrhosis independent of child-pugh stage and meld score

Journal of hepatology, 2015-04, Vol.62, p.S349-S350

2015

Volltextzugriff (PDF)

Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient

Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102061, Article 102061

2020

Volltextzugriff (PDF)

Iron and oxidative damage in the multiple sclerosis brain

Journal of the neurological sciences, 2013-10, Vol.333, p.e386-e387

2013

Volltextzugriff (PDF)

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

Movement disorders, 2019-02, Vol.34 (2), p.180-198

2019

Volltextzugriff (PDF)

720 vWF-ANTIGEN CORRELATES WITH SEVERITY OF PORTAL HYPERTENSION

Journal of hepatology, 2013-04, Vol.58, p.S292-S292

2013

Volltextzugriff (PDF)

P1027 IS THE ELF-SCORE A VALID SUBSTITUTION FOR HVPG TO DETECT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) NON-INVASIVELY?

Journal of hepatology, 2014-04, Vol.60 (1), p.S417-S417

2014

Volltextzugriff (PDF)

P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-Ag

Journal of hepatology, 2014-04, Vol.60 (1), p.S244-S245

2014

Volltextzugriff (PDF)

LP38 : Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from austria

Journal of hepatology, 2015-04, Vol.62, p.S282-S283

2015

Volltextzugriff (PDF)

7T MRI: Measuring white matter changes in MS and iron content in brain

Journal of the neurological sciences, 2019-10, Vol.405, p.35-36

2019

Volltextzugriff (PDF)

P1083 VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SEVERE ADVERSE EVENTS IN HCV PATIENTS WITH DAA BASED TRIPLE THERAPY

Journal of hepatology, 2014-04, Vol.60 (1), p.S438-S438

2014

Volltextzugriff (PDF)

Veins in plaques of multiple sclerosis patients — /INS;A longitudinal magnetic resonance imaging study at 7 Tesla

Journal of the neurological sciences, 2013-10, Vol.333, p.e410-e410

2013

Volltextzugriff (PDF)

Disease-specific mechanisms in cortical multiple sclerosis lesions

Journal of the neurological sciences, 2013-10, Vol.333, p.e392-e393

2013

Volltextzugriff (PDF)

Impaired plasticity of macrophages in X-linked adrenoleukodystrophy

Brain (London, England : 1878), 2018-08, Vol.141 (8), p.2329-2342

2018

Volltextzugriff (PDF)

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

Annals of neurology, 2024-07, Vol.96 (1), p.1-20

2024

Volltextzugriff (PDF)

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

The New England journal of medicine, 2024-02, Vol.390 (6), p.497-509

2024

Volltextzugriff (PDF)

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

The Lancet (British edition), 2022-04, Vol.399 (10333), p.1383-1390

2022

Volltextzugriff (PDF)

Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen

Journal of antimicrobial chemotherapy, 2020-11, Vol.75 (11), p.3349-3358

2020

Volltextzugriff (PDF)

Stroke Care Pathway ensures high-quality stroke management in the COVID-19 pandemic

Scientific reports, 2023-04, Vol.13 (1), p.5587-5587, Article 5587

2023

Volltextzugriff (PDF)

Real world experience of retreatment of chronic hepatitis C patients who failed IFN-free DAA therapy

Journal of hepatology, 2018-04, Vol.68, p.S279-S280

2018

Volltextzugriff (PDF)

THU-336 - Real world experience of retreatment of chronic hepatitis C patients who failed IFN-free DAA therapy

Journal of hepatology, 2018-04, Vol.68, p.S279-S280

2018

Volltextzugriff (PDF)

VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SERIOUS ADVERSE EVENTS IN HCV PATIENTS WITH INTERFERON TRIPLE THERAPY

Digestive and liver disease, 2016-10, Vol.48 (10), p.1194-1199

2016

Volltextzugriff (PDF)

1 – 25 von 720

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(606)
Mit Volltextzugriff
(671)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(425)
Life Sciences & Biomedicine
(244)
Humans
(167)
Technology
(122)
Male
(112)
Female
(108)
Physical Sciences
(108)
Chemistry
(90)
Neurosciences & Neurology
(85)
Middle Aged
(78)
Aged
(75)
Clinical Neurology
(73)
Engineering
(71)
Cardiovascular System & Cardiology
(66)
Adult
(58)
Neurosciences
(51)
Peripheral Vascular Disease
(48)
Blood Pressure
(46)
Aged, 80 And Over
(45)
Engineering, Electrical & Electronic
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Artery Research
(72)
Journal Of Hypertension
(21)
Cheminform
(18)
Journal Of Hepatology
(17)
Stroke
(11)
Arkivoc
(8)
Arkivoc Free Online Journal Of Organic Chemistry
(8)
Monatshefte Für Chemie
(8)
Analytical And Bioanalytical Chemistry
(7)
Annals Of Neurology
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla

Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

P0836 : Treatment response rates in a real life cohort of patients with advanced liver disease and organ transplantation

P0130 : VITRO-Score (vWF-Ag/thrombocytes) predicts mortality in patients with liver cirrhosis independent of child-pugh stage and meld score

Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient

Iron and oxidative damage in the multiple sclerosis brain

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

720 vWF-ANTIGEN CORRELATES WITH SEVERITY OF PORTAL HYPERTENSION

P1027 IS THE ELF-SCORE A VALID SUBSTITUTION FOR HVPG TO DETECT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) NON-INVASIVELY?

P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-Ag

LP38 : Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from austria

7T MRI: Measuring white matter changes in MS and iron content in brain

P1083 VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SEVERE ADVERSE EVENTS IN HCV PATIENTS WITH DAA BASED TRIPLE THERAPY

Veins in plaques of multiple sclerosis patients — /INS;A longitudinal magnetic resonance imaging study at 7 Tesla

Disease-specific mechanisms in cortical multiple sclerosis lesions

Impaired plasticity of macrophages in X-linked adrenoleukodystrophy

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen

Stroke Care Pathway ensures high-quality stroke management in the COVID-19 pandemic

Real world experience of retreatment of chronic hepatitis C patients who failed IFN-free DAA therapy

THU-336 - Real world experience of retreatment of chronic hepatitis C patients who failed IFN-free DAA therapy

VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SERIOUS ADVERSE EVENTS IN HCV PATIENTS WITH INTERFERON TRIPLE THERAPY

Suchergebnisse filtern